These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 35880388)

  • 41. Probiotic supplementation in children with cystic fibrosis-a systematic review.
    Ananthan A; Balasubramanian H; Rao S; Patole S
    Eur J Pediatr; 2016 Oct; 175(10):1255-66. PubMed ID: 27576473
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Link between Gut Microbiota and Hepatic Encephalopathy.
    Won SM; Oh KK; Gupta H; Ganesan R; Sharma SP; Jeong JJ; Yoon SJ; Jeong MK; Min BH; Hyun JY; Park HJ; Eom JA; Lee SB; Cha MG; Kwon GH; Choi MR; Kim DJ; Suk KT
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012266
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gut Microbiota and Obesity: A Role for Probiotics.
    Abenavoli L; Scarpellini E; Colica C; Boccuto L; Salehi B; Sharifi-Rad J; Aiello V; Romano B; De Lorenzo A; Izzo AA; Capasso R
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31703257
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The gut microbiota as a novel regulator of cardiovascular function and disease.
    Battson ML; Lee DM; Weir TL; Gentile CL
    J Nutr Biochem; 2018 Jun; 56():1-15. PubMed ID: 29427903
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A New Approach to Polycystic Ovary Syndrome: The Gut Microbiota.
    Yurtdaş G; Akdevelioğlu Y
    J Am Coll Nutr; 2020; 39(4):371-382. PubMed ID: 31513473
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibiotic-induced gut dysbiosis and barrier disruption and the potential protective strategies.
    Duan H; Yu L; Tian F; Zhai Q; Fan L; Chen W
    Crit Rev Food Sci Nutr; 2022; 62(6):1427-1452. PubMed ID: 33198506
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gut microbiota and obesity: An opportunity to alter obesity through faecal microbiota transplant (FMT).
    Lee P; Yacyshyn BR; Yacyshyn MB
    Diabetes Obes Metab; 2019 Mar; 21(3):479-490. PubMed ID: 30328245
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapeutic Potential of the Gut Microbiota in the Prevention and Treatment of Sepsis.
    Haak BW; Prescott HC; Wiersinga WJ
    Front Immunol; 2018; 9():2042. PubMed ID: 30250472
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dysbiosis in Functional Bowel Disorders.
    Enck P; Mazurak N
    Ann Nutr Metab; 2018; 72(4):296-306. PubMed ID: 29694952
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered.
    Qiao YQ; Cai CW; Ran ZH
    J Dig Dis; 2016 Dec; 17(12):800-810. PubMed ID: 27743467
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.
    Suk KT; Kim DJ
    Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):193-204. PubMed ID: 30791767
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dysbiosis of Gut Microbiota Is Associated With the Progression of Radiation-Induced Intestinal Injury and Is Alleviated by Oral Compound Probiotics in Mouse Model.
    Zhao TS; Xie LW; Cai S; Xu JY; Zhou H; Tang LF; Yang C; Fang S; Li M; Tian Y
    Front Cell Infect Microbiol; 2021; 11():717636. PubMed ID: 34760714
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Psoriasis: Interplay between dysbiosis and host immune system.
    Kapoor B; Gulati M; Rani P; Gupta R
    Autoimmun Rev; 2022 Nov; 21(11):103169. PubMed ID: 35964945
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of the gut microbiota in the pathogenesis of coeliac disease and potential therapeutic implications.
    Akobeng AK; Singh P; Kumar M; Al Khodor S
    Eur J Nutr; 2020 Dec; 59(8):3369-3390. PubMed ID: 32651763
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gut Microbiota-Kidney Cross-Talk in Acute Kidney Injury.
    Gong J; Noel S; Pluznick JL; Hamad ARA; Rabb H
    Semin Nephrol; 2019 Jan; 39(1):107-116. PubMed ID: 30606403
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gut enterotypes are stable during Bifidobacterium and Lactobacillus probiotic supplementation.
    Haddad EN; Sugino KY; Tucker RM; Comstock SS
    J Food Sci; 2020 May; 85(5):1596-1604. PubMed ID: 32267970
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gut microbes in neurocognitive and mental health disorders.
    Halverson T; Alagiakrishnan K
    Ann Med; 2020 Dec; 52(8):423-443. PubMed ID: 32772900
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prebiotics, Probiotics, and Acetate Supplementation Prevent Hypertension in a Model of Obstructive Sleep Apnea.
    Ganesh BP; Nelson JW; Eskew JR; Ganesan A; Ajami NJ; Petrosino JF; Bryan RM; Durgan DJ
    Hypertension; 2018 Nov; 72(5):1141-1150. PubMed ID: 30354816
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The gut microbiome and hypertension.
    O'Donnell JA; Zheng T; Meric G; Marques FZ
    Nat Rev Nephrol; 2023 Mar; 19(3):153-167. PubMed ID: 36631562
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential Analysis of Hypertension-Associated Intestinal Microbiota.
    Dan X; Mushi Z; Baili W; Han L; Enqi W; Huanhu Z; Shuchun L
    Int J Med Sci; 2019; 16(6):872-881. PubMed ID: 31337961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.